Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
2024;29:e13031
Similar content being viewed by others Background The injectable glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely used in the management of type 2 diabetes mellitus (T2DM) [1]
But regulatory approvals are never guaranteed, and unexpected safety signals can delay or derail the process
The higher mortality in T2DM occurs mostly owing to cardiovascular diseases
On the basis of the results, no clinically relevant change in the tolerability and safety profiles of semaglutide, metformin, warfarin, atorvastatin or digoxin is anticipated when co-dosing at steady state
US$ 23.88
US$ 24.35
US$ 24.59
US$ 25.13
US$ 28.57
